Biocryst Pharmaceuticals (BCRX) Asset Utilization Ratio (2011 - 2026)
Biocryst Pharmaceuticals' (BCRX) Asset Utilization Ratio came in at 1.84 for Q2 2026, up 54.6% from 1.19 a year earlier and up 1.7% from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
For FY2025, Biocryst Pharmaceuticals' Asset Utilization Ratio stood at 1.74, up 94.6% from FY2024.
- Annual Asset Utilization Ratio has increased for five consecutive years.
- In prior years, Biocryst Pharmaceuticals' Asset Utilization Ratio was 0.89 in FY2024 (+44.0%), 0.62 in FY2023 (+30.5%), 0.48 in FY2022 (+39.7%) and 0.34 in FY2021 (+387.6%).
- The Q2 2026 figure stands as the highest quarterly Asset Utilization Ratio in data going back to Q3 2011.
- On a year-over-year basis, Asset Utilization Ratio has increased in each of the last 19 quarters, with growth averaging 57.3% over the last eight quarters.
- The year-over-year growth in Asset Utilization Ratio has ranged between 6.2% (Q3 2022) and 428.0% (Q4 2021) over the last five years.
- According to Business Quant data, Asset Utilization Ratio for the three prior quarters was 1.81 (Q1 2026), 1.82 (Q4 2025) and 1.33 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,131.67 Bn | 1,100.26 Bn | 19.71 Bn | 0.62 |
| 2 | Johnson & Johnson | 614.28 Bn | 532.81 Bn | 17.26 Bn | 0.49 |
| 3 | AbbVie | 503.23 Bn | 476.34 Bn | 12.70 Bn | 0.47 |
| 4 | Merck | 368.28 Bn | 322.66 Bn | 12.21 Bn | 0.52 |
| 5 | Novartis Ag | 298.22 Bn | 262.21 Bn | 11.24 Bn | 0.46 |
| 6 | Astrazeneca | 261.55 Bn | 235.23 Bn | 12.86 Bn | 0.51 |
| 7 | Amgen | 235.92 Bn | 191.31 Bn | 7.24 Bn | 0.40 |
| 8 | Gilead Sciences | 190.78 Bn | 164.98 Bn | 6.22 Bn | 0.58 |
| 9 | Pfizer | 169.66 Bn | 116.31 Bn | 10.94 Bn | 0.31 |
| 10 | Biocryst Pharmaceuticals | 1.99 Bn | 915.27 Mn | 214.41 Mn | 1.84 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.84 |
| Mar 31, 2026 | 1.81 |
| Dec 31, 2025 | 1.82 |
| Sep 30, 2025 | 1.33 |
| Jun 30, 2025 | 1.19 |
| Mar 31, 2025 | 1.04 |
| Dec 31, 2024 | 0.92 |
| Sep 30, 2024 | 0.86 |
| Jun 30, 2024 | 0.81 |
| Mar 31, 2024 | 0.72 |
| Dec 31, 2023 | 0.64 |
| Sep 30, 2023 | 0.60 |
| Jun 30, 2023 | 0.59 |
| Mar 31, 2023 | 0.55 |
| Dec 31, 2022 | 0.49 |
| Sep 30, 2022 | 0.45 |
| Jun 30, 2022 | 0.39 |
| Mar 31, 2022 | 0.34 |
| Dec 31, 2021 | 0.37 |
| Sep 30, 2021 | 0.42 |
API Access
Biocryst Pharmaceuticals Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();